Sign up to save your podcasts
Or
Share The ESG Weekly: COVID‐19 vaccines peer out the lab door at the big, wide world and worker wellbeing gets squeezed in competitive South Korean logistics market
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The ESG Weekly: COVID‐19 vaccines peer out the lab door at the big, wide world and worker wellbeing gets squeezed in competitive South Korean logistics market
Pfizer‐BioNTech, Moderna and Oxford‐Astra Zeneca are all looking to roll out COVID‐19 vaccines after successful phase 3 trials. Amid the hope of locked down populations, we look at the ESG risks of what’s coming next. Meanwhile, although the pandemic has created an e-commerce boom for South Korea’s logistics companies, delivery workers are bearing the burden of competition. And finally, we walk through some of the longer-term forces moulding governance practices at banks.
View all episodes
By MSCI ESG Research LLC
4.8
133133 ratings
Pfizer‐BioNTech, Moderna and Oxford‐Astra Zeneca are all looking to roll out COVID‐19 vaccines after successful phase 3 trials. Amid the hope of locked down populations, we look at the ESG risks of what’s coming next. Meanwhile, although the pandemic has created an e-commerce boom for South Korea’s logistics companies, delivery workers are bearing the burden of competition. And finally, we walk through some of the longer-term forces moulding governance practices at banks.
More shows like Sustainability Now
View all
Economist Podcasts
4,182 Listeners
Energy Gang
1,253 Listeners
Columbia Energy Exchange
398 Listeners
Interchange Recharged
501 Listeners
FT News Briefing
665 Listeners
Redefining Energy
133 Listeners
Behind the Money
223 Listeners
Outrage + Optimism: The Climate Podcast
478 Listeners
Switched On
103 Listeners
All Things Sustainable
63 Listeners
Climate Rising
78 Listeners
The Climate Question
175 Listeners
Catalyst with Shayle Kann
270 Listeners
The Green Blueprint
210 Listeners
Zero: The Climate Race
226 Listeners